Quantification of the contribution of Type 1 and Type 2 angiotensin II receptors to the net tissue specific effect of angiotensin II

Annals of Biomedical Engineering

Volumn 28, Issue 6, 2000, Pages 653-664

  Nora, Elizabeth H ^a   Tonellato, Peter J ^a   Greene, Andrew S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPOSITION EFFECTS; CONTROLLED DRUG DELIVERY; MATHEMATICAL MODELS; MICROCIRCULATION; NUMERICAL ANALYSIS; PHYSIOLOGY; PROTEINS; REACTION KINETICS; RNA; SODIUM; TISSUE;

ANGIOTENSIN; KINETIC ANALYSIS; NET TISSUE SPECIFIC EFFECT; PHYSIOLOGIC STIMULUS; RECEPTOR; RENIN;

CARDIOVASCULAR SYSTEM;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; LIGAND; PROTEIN;

ADRENAL GLAND; ANIMAL; AORTA; ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; DRUG ANTAGONISM; MALE; PHYSIOLOGY; RAT; SENSITIVITY AND SPECIFICITY; SODIUM INTAKE; SPRAGUE DAWLEY RAT; STATISTICAL MODEL; VALIDATION STUDY; WESTERN BLOTTING;

ADRENAL GLANDS; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; AORTA; BLOTTING, WESTERN; LIGANDS; LINEAR MODELS; MALE; MODELS, BIOLOGICAL; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; SENSITIVITY AND SPECIFICITY; SODIUM, DIETARY;

EID: 0033624374     PISSN: 00906964     EISSN: None     Source Type: Journal    
DOI: 10.1114/1.1305911     Document Type: Article

References (33)

1. Aguilera, G., A. Schirar, A. Baukal, and K. J. Catt. Angiotensin II Receptors: Properties and regulation in adrenal glomerulosa cells. Circ. Res. 46:I118-I127, 1980.
2. Bowman, W. C., and M. J. Rand. Textbook of Pharmacology, 2nd ed., Blackwell Scientific, 1980: 13-39,43.
3. Dahlof, B.. Effect of angiotensin II blockade on cardiac hypertrophy and remodeling: a review. J. Hum. Hypertens. 9:S37-S44, 1995.
4. 2) binding sites in R3T3 cells. Mol. Pharmacol. 40:360-367, 1991.
5. Ferrario, C. M., and J. M. Flack. Pathologic consequences of increased angiotensin II activity. Cardiovasc. Drugs Therapy 10:511-518, 1996.
6. Fyhrquist, F., K. Metsarinne, and I. Tikkanen. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. J. Hum. Hypertens. 9:S19-S24, 1995.
7. Garg, R., and S. Yusuf. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. J. Am. Med. Assoc. 273:1450-1456, 1995.
8. Griffin, S., W. Brown, F. MacPherson, J. McGrath, V. Wilson, N. Korsgaard, M. Mulvany, and A. Lever. Angiotensin II causes vascular hypertrophy in part by non-pressor mechanism. Hypertension (Dallas) 17:626-635, 1991.
9. Hernandez, I., A. W. Cowley, Jr., J. H. Lombard, and A. S. Greene. Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal rats. Am. J. Physiol. 263:H664-H667, 1992.
10. Ichiki, T., P. A. Labosky, C. Shiota, S. Okuyama, Y. Imagawa, A. Fogo, F. Niimura, I. Ichikawa, B. L. M. Hogan, and T. Inagami. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type 2 receptor. Nature (London) 377:748-750, 1995.
11. Ito, M., M. I. Oliverio, P. J. Mannon, C. F. Best, M. Maeda, O. Smithies, and T. M. Coffman. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl. Acad. Sci. USA 92:3521-3525, 1995.
12. Iwai, N., and T. Inagami. Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem. Biophys. Res. Commun. 182:1094-1099, 1992.
13. Kitami, Y., T. Okura, K. Marumoto, R. Wakam ya, and K. Hiwada. Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem. Biophys. Res. Commun. 188:446-452, 1992.
14. Kwok, Y. C., and G. J. Moore. Photoaffinity labeling of the rat isolated portal vein: Determination of affinity constants and "spare" receptors for angiotensin II and III. J. Pharmacol. Exp. Ther: 231:137-140, 1984.
15. Kwok, Y. C., and G. J. Moore. Comparison of angiotensin receptors in isolated smooth muscle tissues by photoaffinity labeling. Eur: J. Pharmacol. 115:53-58, 1985.
16. Lauffenburger, D. A., and J. J. Linderman. Receptors: Models for Binding, Trafficking, and Signaling, London: Oxford University, 1993: 13-43, 247-251.
17. Llorens-Cortez, C., B. Greenberg, H. Huang, and P. Corvol. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension (Dallas) 24:538-548, 1994.
18. Munzenmaier, D. H., and A. S. Greene. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension (Dallas) 27:760-765, 1956.
19. Nora, E. H., D. H. Munzenmaier, and A. S. Greene. Regulation of angiotensin II receptors in cremasteric microvessels by sodium intake. FASEB J. 10:A58, 1996.
20. Nora, E. H., D. H. Munzenmaier, F. M. Hansen-Smith, J. H. Lombard, and A. S. Greene. Localization of the angiotensin II type 2 receptor in the microcirculation of skeletal muscle. Am. J. Physiol. 275:H1395-H1403, 1998.
21. 2) receptor protein in rat kidney. Hypertension (Dallas) 30:1238-1246, 1997.
22. Pernollet, M.-G., M. A. Devynck, P. G. Matthews, and P. Meyer. Post-nephrectomy changes in adrenal angiotensin II receptors in the rat: Influence of exogenous angiotensin and a competitive inhibitor. Eur. J. Pharmaco. 43:361-372, 1977.
23. Raizada, M. K., M. I. Phillips, and C. Sumners. Cellular and Molecular Biology of the Renin-Angiotensin System. Boca Raton: CRC, 1993.
24. Rakugi, H., D. Wang, V. Dzau, and R. Pratt, Potential importance of tissue angiotensin-converting enzyme inhibition preventing neointima formation. Circulation 50:449-455, 1994.
25. Rieder, M. J., R. J. Roman, and A. S. Greene. Reversal of microvascular rarefaction and reduced renal mass hypertension. Hypertension (Dallas) 30:120-127, 1997.
26. Riordan, J. F. Angiotensin II: Biosynthesis, molecular recognition, and signal transduction. Cell. Mol. Neurobiol. 15:637-651, 1995.
27. 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler. Thromb. Vasc. Biol. 17:257-264, 1997.
28. Scheuer, D. A., and M. H. Perrone. Angiotensin type 2 receptors mediate the depressor phase of biphasic pressure response to angiotensin. Am. J. Physiol. 264:R917-R923, 1993.
29. Stoll, M., U. M. Steckelings, M. Paul, S. P. Bottari, R. Metzger, and T. Unger. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 95:651-657, 1995.
30. Unger, T., O. Chung, T. Csikos, J. Culman, S. Gallinat, P. Gohlke, S. Hohle, S. Meffert, M. Stoll, U. Stroth, and Y. Zhu. Angiotensin receptors. J. Hypertens. 14:S95-S103, 1996.
31. Viswanathan, M., M. K. Tsutsumi, F. M. A. Correa, and J. M. Saavedra. Changes in the expression of angiotensin receptor subtypes in the rat aorta during development. Biochem. Biophys. Res. Commun. 179:1361-1367, 1991.
32. Wang, D. H., and R. L. Prewitt. Longitudinal effect of captopril on aortic and arteriolar development in normotensive animals. Am. J. Physiol. 260:H1959-H1965, 1991.
33. Weber, D. S., J. C. Frisbee, and J. H. Lombard. Selective potentiation of angiotensin-induced constriction of skeletal muscle resistance arteries by chronic elevations in dietary salt intake. Microvasc. Res. 57:310-319, 1999.